1987 - Bachelor's Degree in Clinical Medicine: Xuzhou Medical College
1990 - Master's Degree in Surgery: Xuzhou Medical College
1996 - Doctorate in Surgery: Shanghai Medical University
Published over 180 SCI papers, 90 as corresponding/first author
Chief Editor of 3 books, Co-editor of 3 books, Main translator of 1 book
Received 12 patents
First author of National Natural Science Second Prize, Provincial and Ministerial First Prize
Fifth author of National Science and Technology Progress First Prize
Current - Fudan University affiliated Huashan Hospital - Director of Surgery
Current - Huashan North Hospital - Executive Vice President
Current - Fudan University Tumor Metastasis Research Institute - Director
Shanghai Natural Science Peony Award
Tan Jiazhen Life Science Award Innovation Award
Shanghai May 1st Labor Medal
Shanghai Craftsman Award
National Outstanding Youth Fund
Ministry of Education Changjiang Distinguished Professor
Research
Improving the efficacy of gastrointestinal tumor surgery
MFN1-dependent alteration of mitochondrial dynamics drives hepatocellular carcinoma metastasis by glucose metabolic reprogramming, Zhang Z, Li TE, Chen M, Xu D, Zhu Y, Hu BY, Lin ZF, Pan JJ, Wang X, Wu C, Zheng Y, Lu L, Jia HL, Gao S, Dong QZ, Qin LX, 2020
Increased neutrophil extracellular traps promote metastasis potential of hepatocellular carcinoma via provoking tumorous inflammatory response, Yang LY, Luo Q, Lu L, Zhu WW, Sun HT, Wei R, Lin ZF, Wang XY, Wang CQ, Lu M, Jia HL, Chen JH, Zhang JB, Qin LX, 2020
Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade, Zhu Y, Yang J, Xu D, Gao XM, Zhang Z, Hsu JL, Li CW, Lim SO, Sheng YY, Zhang Y, Li JH, Luo Q, Zheng Y, Zhao Y, Lu L, Jia HL, Hung MC, Dong QZ, Qin LX, 2019
ACOT12-Dependent Alteration of Acetyl-CoA drives hepatocellular carcinoma metastasis by epigenetic induction of epithelial-mesenchymal transition, Lu M, Zhu WW, Wang X, Tang JJ, Zhang KL, Yu GY, Shao WQ, Lin ZF, Wang SH, Lu L, Zhou J, Wang LX, Jia HL, Dong QZ, Chen JH, Lu JQ, Qin LX, 2019
Current perspectives of cancer-associated fibroblast in therapeutic resistance: potential mechanism and future strategy, Kadel D, Zhang Y, Sun HR, Zhao Y, Dong QZ, Qin LX, 2019
Mutated EPHA2 is a target for combating lymphatic metastasis in intrahepatic cholangiocarcinoma, Sheng Y, Wei J, Zhang Y, Gao X, Wang Z, Yang J, Yan S, Zhu Y, Zhang Z, Xu D, Wang C, Zheng Y, Dong Q, Qin L, 2019
LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer, Zhao J, Du P, Cui P, Qin Y, Hu C, Wu J, Zhou Z, Zhang W, Qin L, Huang G, 2018
C-C chemokine receptor type 1 mediates osteopontin-promoted metastasis in hepatocellular carcinoma, Zhu Y, Gao XM, Yang J, Xu D, Zhang Y, Lu M, Zhang Z, Sheng YY, Li JH, Yu XX, Zheng Y, Dong QZ, Qin LX, 2018
FOXQ1/NDRG1 axis exacerbates hepatocellular carcinoma initiation via enhancing crosstalk between fibroblasts and tumor cells, Luo Q, Wang CQ, Yang LY, Gao XM, Sun HT, Zhang Y, Zhang KL, Zhu Y, Zheng Y, Sheng YY, Lu L, Jia HL, Yu WQ, Liu J, Dong QZ, Qin LX, 2018
Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma, Gao X, Sheng Y, Yang J, Wang C, Zhang R, Zhu Y, Zhang Z, Zhang K, Yan S, Sun H, Wei J, Wang X, Yu X, Zhang Y, Luo Q, Zheng Y, Qiao P, Zhao Y, Dong Q, Qin L, 2018
The dual blockade of MET and VEGFR2 signaling demonstrates pronounced inhibition on tumor growth and metastasis of hepatocellular carcinoma, Zhang Y, Gao X, Zhu Y, Kadel D, Sun H, Chen J, Luo Q, Sun H, Yang L, Yang J, Sheng Y, Zheng Y, Zhu K, Dong Q, Qin L, 2018
Prospero-related homeobox 1 drives angiogenesis of hepatocellular carcinoma through selectively activating interleukin-8 expression, Liu Y, Zhang Y, Wang S, Dong QZ, Shen Z, Wang W, Tao S, Gu C, Liu J, Xie Y, Qin LX, 2017
Tissue-specific significance of BAP1 gene mutation in prognostic prediction and molecular taxonomy among different types of cancer, Wang XY, Wang Z, Huang JB, Ren XD, Ye D, Zhu WW, Qin LX, 2017
Apatinib is effective for treatment of advanced hepatocellular carcinoma, Kong Y, Sun L, Hou Z, Zhang Y, Chen P, Cui Y, Zhu X, Song T, Li Q, Li H, Zhang T, Qin L, 2017
Properties and feasibility of using cancer stem cells in clinical cancer treatment, Gao XM, Zhang R, Dong QZ, Qin LX, 2016
Bcl-2 expression is a poor predictor for hepatocellular carcinoma prognosis of andropause-age patients, Zhang XF, Yang X, Jia HL, Zhu WW, Lu L, Shi W, Zhang H, Chen JH, Tao YF, Wang ZX, Yang J, Wang LX, Lu M, Zheng Y, Zhao J, Dong QZ, Qin LX, 2016
Interleukin-6 enhances cancer stemness and promotes metastasis of hepatocellular carcinoma via up-regulating osteopontin expression, Wang CQ, Sun HT, Gao XM, Ren N, Sheng YY, Wang Z, Zheng Y, Wei JW, Zhang KL, Yu XX, Zhu Y, Luo Q, Yang LY, Dong QZ, Qin LX, 2016
GOLM1 modulates EGFR/RTK cell-surface recycling to drive hepatocellular carcinoma metastasis, Ye QH, Zhu WW, Zhang JB, Qin Y, Lu M, Lin GL, Guo L, Zhang B, Lin ZH, Roessler S, Forgues M, Jia HL, Lu L, Zhang XF, Lian BF, Xie L, Dong QZ, Tang ZY, Wang XW, Qin LX, 2016
Area of Focus
Oncology | Symptom Management | Palliative Care | Vascular Access | Nursing | Quality Evaluation | Cancer | Patient Care | Clinical Practice | Research
Area of Focus
Infectious Diseases | Diagnosis | Treatment | Pathogenesis | Research | Epidemiology | Virology | Immunology | Clinical Trials | Public Health
Area of Focus
Chronic Disease | Management | Healthcare | Prevention | Treatment | Research | Patient Care | Medical Science | Public Health | Clinical Practice
